Stocks News

LAST PRICE
114.2800
TODAY'S CHANGE (%)
Trending Up3.7800 (3.4208%)

Bid / Lots
114.0600/ 8
Ask / Lots
114.2900/ 8
Open / Previous Close
110.6800 / 110.5000
Day Range
Low 110.5000
High 114.4850
52 Week Range
Low 78.6700
High 173.2500
Volume
328,471
below average

Search Criteria

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
Company	Country	Symbol

TD Direct Investing offers more research reports than any other discount brokerage in Canada. Provided from the industry's most trusted sources, our service includes timely, relevant information for the current trading day and comprehensive industry, sector, and insider trading reports for further analysis.

Open a New Account, or Login if you're a client.

Nov 20, 2024
- DJ S&P 500 Futures Climb In Premarket Trading; Target, Fabrinet Lag, from 7:30AM ET on Wednesday Nov 20, 2024 by Dow Jones
  7:30AM ET on Wednesday Nov 20, 2024 by Dow Jones
  Companies Mentioned: FN, TGT, SRPT, GLBE, WIX, KEYS, DLB
  
  This article was automatically generated by Barrons.com using technology from Automated Insights.
  
  With U.S. stock markets set to open in two hours, Dolby Laboratories Inc. Cl A (DLB) was up 12.8% in pre-market trading, and Wix.com Ltd. (WIX) was up 11.0%.
Nov 11, 2024
- DJ Sarepta's Valuation Seen As An Easy Pill to Swallow -- Market Talk, from 2:17PM ET on Monday Nov 11, 2024 by Dow Jones
  2:17PM ET on Monday Nov 11, 2024 by Dow Jones
  Companies Mentioned: SRPT
  
  1417 ET - JPMorgan analysts think Sarepta Therapeutics' Duchenne gene therapy is the cure to the stock's low valuation. They say in a research note that investors were disappointed in Sarepta's implied guidance for its Duchenne muscular dystrophy treatment, called Elevidys. But that selloff is a fresh opportunity: They say the stock's valuation is still underappreciating the potential future sales of the treatment. They say that investors are not pricing in the full potential for Elevidys's label expansion, presenting a buying opportunity. The FDA expanded Elevidys's approval to individuals 4 years old and up in June. Shares fall 2.8%. (ben.glickman@wsj.com; @benglickman)
Nov 7, 2024
- DJ Sarepta Therapeutics Is Maintained at Buy by Guggenheim, from 2:36PM ET on Thursday Nov 07, 2024 by Dow Jones
  2:36PM ET on Thursday Nov 07, 2024 by Dow Jones
  Companies Mentioned: SRPT
  
  Ratings actions from Benzinga: https://www.benzinga.com/quote/SRPT/analyst-ratings
  
  (END) Dow Jones Newswires
  
  November 07, 2024 14:36 ET (19:36 GMT)
- DJ Sarepta Therapeutics Is Maintained at Outperform by Baird, from 12:56PM ET on Thursday Nov 07, 2024 by Dow Jones
  12:56PM ET on Thursday Nov 07, 2024 by Dow Jones
  Companies Mentioned: SRPT
  
  Ratings actions from Benzinga: https://www.benzinga.com/quote/SRPT/analyst-ratings
  
  (END) Dow Jones Newswires
  
  November 07, 2024 12:56 ET (17:56 GMT)
- DJ Sarepta Therapeutics Is Maintained at Outperform by Evercore ISI Group, from 9:18AM ET on Thursday Nov 07, 2024 by Dow Jones
  9:18AM ET on Thursday Nov 07, 2024 by Dow Jones
  Companies Mentioned: SRPT
  
  Ratings actions from Benzinga: https://www.benzinga.com/quote/SRPT/analyst-ratings
  
  (END) Dow Jones Newswires
  
  November 07, 2024 09:18 ET (14:18 GMT)

Today
- The Schall Law Firm Invites Stockholder Participation In An Inquiry Into Medpace Holdings Inc's Possible Securities Law Violations, from 1 hour ago by Accesswire
  1 hour ago by Accesswire
  Companies Mentioned: MEDP
- The Schall Law Firm Invites Stockholder Participation In An Inquiry Into Medpace Holdings Inc's Possible Securities Law Violations, from 1 hour ago by Dow Jones
  1 hour ago by Dow Jones
  Companies Mentioned: MEDP
- MEDP Investigation Reminder: Kessler Topaz Meltzer & Check, LLP Encourages Medpace Holdings, Inc. (MEDP) Investors with Significant Losses to Contact the Firm, from 3 hours ago by Dow Jones
  3 hours ago by Dow Jones
  Companies Mentioned: MEDP
- MEDP Investigation Reminder: Kessler Topaz Meltzer & Check, LLP Encourages Medpace Holdings, Inc. (MEDP) Investors with Significant Losses to Contact the Firm, from 3 hours ago by Newsfile
  3 hours ago by Newsfile
  Companies Mentioned: MEDP
Yesterday
- Alert of Investigation of MEDP: Kessler Topaz Meltzer & Check, LLP Encourages Medpace Holdings, Inc. (NASDAQ: MEDP) Investors with Significant Losses to Contact the Firm, from 18 hours ago by Accesswire
  18 hours ago by Accesswire
  Companies Mentioned: MEDP
- Alert of Investigation of MEDP: Kessler Topaz Meltzer & Check, LLP Encourages Medpace Holdings, Inc. (NASDAQ: MEDP) Investors with Significant Losses to Contact the Firm, from 18 hours ago by Dow Jones
  18 hours ago by Dow Jones
  Companies Mentioned: MEDP
- Medpace Holdings, Inc. Is Being Investigated For Fraud And Investors With Losses Are Encouraged To Reach Out To The Schall Law Firm, from 23 hours ago by Accesswire
  23 hours ago by Accesswire
  Companies Mentioned: MEDP
- MEDP Investigation Reminder: Kessler Topaz Meltzer & Check, LLP Encourages Medpace Holdings, Inc. (NASDAQ:MEDP) Investors with Significant Losses to Contact the Firm, from 23 hours ago by Accesswire
  23 hours ago by Accesswire
  Companies Mentioned: MEDP
- Medpace Holdings, Inc. Is Being Investigated For Fraud And Investors With Losses Are Encouraged To Reach Out To The Schall Law Firm, from 11:47AM ET on Thursday Nov 21, 2024 by Dow Jones
  11:47AM ET on Thursday Nov 21, 2024 by Dow Jones
  Companies Mentioned: MEDP
- MEDP Investigation Alert: Kessler Topaz Meltzer & Check, LLP Encourages Medpace Holdings, Inc. (NASDAQ: MEDP) Investors with Significant Losses to Contact the Firm, from 9:46AM ET on Thursday Nov 21, 2024 by Newsfile
  9:46AM ET on Thursday Nov 21, 2024 by Newsfile
  Companies Mentioned: MEDP

Sarepta Therapeutics Inc
NASDAQ:SRPTUnited States

Search Criteria

Nov 20, 2024

DJ S&P 500 Futures Climb In Premarket Trading; Target, Fabrinet Lag, from 7:30AM ET on Wednesday Nov 20, 2024 by Dow Jones

Nov 11, 2024

DJ Sarepta's Valuation Seen As An Easy Pill to Swallow -- Market Talk, from 2:17PM ET on Monday Nov 11, 2024 by Dow Jones

Nov 7, 2024

DJ Sarepta Therapeutics Is Maintained at Buy by Guggenheim, from 2:36PM ET on Thursday Nov 07, 2024 by Dow Jones

DJ Sarepta Therapeutics Is Maintained at Outperform by Baird, from 12:56PM ET on Thursday Nov 07, 2024 by Dow Jones

DJ Sarepta Therapeutics Is Maintained at Outperform by Evercore ISI Group, from 9:18AM ET on Thursday Nov 07, 2024 by Dow Jones

Peers Headlines

Today

The Schall Law Firm Invites Stockholder Participation In An Inquiry Into Medpace Holdings Inc's Possible Securities Law Violations, from 1 hour ago by Accesswire

The Schall Law Firm Invites Stockholder Participation In An Inquiry Into Medpace Holdings Inc's Possible Securities Law Violations, from 1 hour ago by Dow Jones

MEDP Investigation Reminder: Kessler Topaz Meltzer & Check, LLP Encourages Medpace Holdings, Inc. (MEDP) Investors with Significant Losses to Contact the Firm, from 3 hours ago by Dow Jones

MEDP Investigation Reminder: Kessler Topaz Meltzer & Check, LLP Encourages Medpace Holdings, Inc. (MEDP) Investors with Significant Losses to Contact the Firm, from 3 hours ago by Newsfile

Yesterday

Alert of Investigation of MEDP: Kessler Topaz Meltzer & Check, LLP Encourages Medpace Holdings, Inc. (NASDAQ: MEDP) Investors with Significant Losses to Contact the Firm, from 18 hours ago by Accesswire

Alert of Investigation of MEDP: Kessler Topaz Meltzer & Check, LLP Encourages Medpace Holdings, Inc. (NASDAQ: MEDP) Investors with Significant Losses to Contact the Firm, from 18 hours ago by Dow Jones

Medpace Holdings, Inc. Is Being Investigated For Fraud And Investors With Losses Are Encouraged To Reach Out To The Schall Law Firm, from 23 hours ago by Accesswire

MEDP Investigation Reminder: Kessler Topaz Meltzer & Check, LLP Encourages Medpace Holdings, Inc. (NASDAQ:MEDP) Investors with Significant Losses to Contact the Firm, from 23 hours ago by Accesswire

Medpace Holdings, Inc. Is Being Investigated For Fraud And Investors With Losses Are Encouraged To Reach Out To The Schall Law Firm, from 11:47AM ET on Thursday Nov 21, 2024 by Dow Jones

MEDP Investigation Alert: Kessler Topaz Meltzer & Check, LLP Encourages Medpace Holdings, Inc. (NASDAQ: MEDP) Investors with Significant Losses to Contact the Firm, from 9:46AM ET on Thursday Nov 21, 2024 by Newsfile